nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00214	0.00903	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00211	0.00893	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.00211	0.00892	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.00206	0.00869	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.00192	0.00813	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.00188	0.00795	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—KISS1R—stomach cancer	0.00188	0.00793	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00183	0.00774	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—F2R—stomach cancer	0.00183	0.00773	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00181	0.00765	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00176	0.00745	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—ANXA1—stomach cancer	0.00172	0.00727	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KISS1R—stomach cancer	0.0017	0.0072	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.0017	0.00719	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.00165	0.00697	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—stomach cancer	0.00164	0.00692	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—HRH4—stomach cancer	0.00161	0.00679	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00156	0.00659	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—stomach cancer	0.00154	0.0065	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—KISS1—stomach cancer	0.00143	0.00605	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—AGTR2—stomach cancer	0.00139	0.00589	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—F2R—stomach cancer	0.00138	0.00583	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—HRH4—stomach cancer	0.00136	0.00573	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—HTR1A—stomach cancer	0.00134	0.00567	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.00134	0.00565	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—stomach cancer	0.00131	0.00553	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ANXA1—stomach cancer	0.0013	0.00548	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—KISS1R—stomach cancer	0.00126	0.00531	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRB1—stomach cancer	0.00126	0.00531	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HRH4—stomach cancer	0.00123	0.00521	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00123	0.00518	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00121	0.00512	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—KISS1—stomach cancer	0.00121	0.00511	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00118	0.00499	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KISS1R—stomach cancer	0.00114	0.00482	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.00114	0.00482	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.0011	0.00466	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KISS1—stomach cancer	0.0011	0.00464	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RGS2—stomach cancer	0.00104	0.00439	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GAST—stomach cancer	0.00104	0.00439	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRB2—stomach cancer	0.00102	0.0043	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KISS1R—stomach cancer	0.00101	0.00425	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GLI3—stomach cancer	0.00101	0.00425	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RBP1—stomach cancer	0.00096	0.00406	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RGS2—stomach cancer	0.000944	0.00399	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GAST—stomach cancer	0.000944	0.00399	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—AGTR2—stomach cancer	0.000934	0.00394	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—F2R—stomach cancer	0.000923	0.0039	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HRH4—stomach cancer	0.000908	0.00384	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—HTR1A—stomach cancer	0.000899	0.0038	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000894	0.00378	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ANXA1—stomach cancer	0.000868	0.00367	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ADRB1—stomach cancer	0.000841	0.00355	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRH4—stomach cancer	0.000825	0.00349	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000824	0.00348	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—KISS1—stomach cancer	0.00081	0.00342	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AGTR2—stomach cancer	0.000788	0.00333	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—WWOX—stomach cancer	0.000783	0.00331	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—F2R—stomach cancer	0.000779	0.00329	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—HTR1A—stomach cancer	0.000759	0.00321	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000736	0.00311	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KISS1—stomach cancer	0.000735	0.00311	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ANXA1—stomach cancer	0.000733	0.0031	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRH4—stomach cancer	0.000728	0.00308	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—WIF1—stomach cancer	0.000728	0.00308	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AGTR2—stomach cancer	0.000716	0.00302	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADRB1—stomach cancer	0.00071	0.003	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—F2R—stomach cancer	0.000708	0.00299	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GAST—stomach cancer	0.000696	0.00294	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—RGS2—stomach cancer	0.000696	0.00294	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HTR1A—stomach cancer	0.000689	0.00291	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ADRB2—stomach cancer	0.000681	0.00288	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KISS1R—stomach cancer	0.000674	0.00285	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLI3—stomach cancer	0.000674	0.00285	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKAB1—stomach cancer	0.000672	0.00284	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ANXA1—stomach cancer	0.000665	0.00281	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KISS1—stomach cancer	0.000649	0.00274	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RNF43—stomach cancer	0.000649	0.00274	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000645	0.00273	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ADRB1—stomach cancer	0.000644	0.00272	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RBP1—stomach cancer	0.000643	0.00272	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GAST—stomach cancer	0.000632	0.00267	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RGS2—stomach cancer	0.000632	0.00267	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FST—stomach cancer	0.000578	0.00244	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADRB2—stomach cancer	0.000575	0.00243	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HBEGF—stomach cancer	0.000566	0.00239	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RGS2—stomach cancer	0.000558	0.00236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GAST—stomach cancer	0.000558	0.00236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGG—stomach cancer	0.000529	0.00223	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGTR2—stomach cancer	0.000528	0.00223	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—WWOX—stomach cancer	0.000524	0.00221	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ADRB2—stomach cancer	0.000522	0.00221	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2R—stomach cancer	0.000522	0.0022	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PPP2R1A—stomach cancer	0.000512	0.00216	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKAA1—stomach cancer	0.000509	0.00215	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR1A—stomach cancer	0.000508	0.00215	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RBP4—stomach cancer	0.000492	0.00208	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—stomach cancer	0.000491	0.00208	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ANXA1—stomach cancer	0.00049	0.00207	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—WIF1—stomach cancer	0.000487	0.00206	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRH4—stomach cancer	0.000487	0.00206	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGTR2—stomach cancer	0.000479	0.00202	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRB1—stomach cancer	0.000475	0.00201	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2R—stomach cancer	0.000474	0.002	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR1A—stomach cancer	0.000461	0.00195	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKAB1—stomach cancer	0.00045	0.0019	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000448	0.00189	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ANXA1—stomach cancer	0.000445	0.00188	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KISS1—stomach cancer	0.000434	0.00184	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RNF43—stomach cancer	0.000434	0.00184	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000432	0.00183	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRB1—stomach cancer	0.000431	0.00182	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000426	0.0018	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000426	0.0018	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGTR2—stomach cancer	0.000423	0.00179	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HSPB1—stomach cancer	0.000423	0.00179	CbGpPWpGaD
Goserelin—Chills—Methotrexate—stomach cancer	0.00042	0.00055	CcSEcCtD
Goserelin—Headache—Irinotecan—stomach cancer	0.000418	0.000548	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—F2R—stomach cancer	0.000418	0.00177	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BMP2—stomach cancer	0.000418	0.00177	CbGpPWpGaD
Goserelin—Hypotension—Capecitabine—stomach cancer	0.000418	0.000547	CcSEcCtD
Goserelin—Insomnia—Docetaxel—stomach cancer	0.000418	0.000547	CcSEcCtD
Goserelin—Paraesthesia—Docetaxel—stomach cancer	0.000415	0.000543	CcSEcCtD
Goserelin—Alopecia—Methotrexate—stomach cancer	0.000414	0.000542	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000414	0.00175	CbGpPWpGaD
Goserelin—Dyspnoea—Docetaxel—stomach cancer	0.000412	0.000539	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AKR1C3—stomach cancer	0.000411	0.00174	CbGpPWpGaD
Goserelin—Somnolence—Docetaxel—stomach cancer	0.00041	0.000538	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—stomach cancer	0.00041	0.000538	CcSEcCtD
Goserelin—Eye disorder—Epirubicin—stomach cancer	0.00041	0.000537	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—stomach cancer	0.000408	0.000534	CcSEcCtD
Goserelin—Erythema—Methotrexate—stomach cancer	0.000408	0.000534	CcSEcCtD
Goserelin—Haemoglobin—Doxorubicin—stomach cancer	0.000408	0.000534	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000407	0.000533	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HTR1A—stomach cancer	0.000407	0.00172	CbGpPWpGaD
Goserelin—Cardiac disorder—Epirubicin—stomach cancer	0.000407	0.000533	CcSEcCtD
Goserelin—Vomiting—Fluorouracil—stomach cancer	0.000407	0.000533	CcSEcCtD
Goserelin—Rhinitis—Doxorubicin—stomach cancer	0.000407	0.000533	CcSEcCtD
Goserelin—Dyspepsia—Docetaxel—stomach cancer	0.000406	0.000532	CcSEcCtD
Goserelin—Haemorrhage—Doxorubicin—stomach cancer	0.000406	0.000531	CcSEcCtD
Goserelin—Hepatitis—Doxorubicin—stomach cancer	0.000406	0.000531	CcSEcCtD
Goserelin—Insomnia—Capecitabine—stomach cancer	0.000404	0.00053	CcSEcCtD
Goserelin—Rash—Fluorouracil—stomach cancer	0.000403	0.000528	CcSEcCtD
Goserelin—Dermatitis—Fluorouracil—stomach cancer	0.000403	0.000528	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000403	0.0017	CbGpPWpGaD
Goserelin—Pharyngitis—Doxorubicin—stomach cancer	0.000402	0.000527	CcSEcCtD
Goserelin—Paraesthesia—Capecitabine—stomach cancer	0.000401	0.000526	CcSEcCtD
Goserelin—Decreased appetite—Docetaxel—stomach cancer	0.000401	0.000526	CcSEcCtD
Goserelin—Headache—Fluorouracil—stomach cancer	0.000401	0.000525	CcSEcCtD
Goserelin—Urinary tract disorder—Doxorubicin—stomach cancer	0.0004	0.000525	CcSEcCtD
Goserelin—Oedema peripheral—Doxorubicin—stomach cancer	0.000399	0.000523	CcSEcCtD
Goserelin—Dyspnoea—Capecitabine—stomach cancer	0.000398	0.000522	CcSEcCtD
Goserelin—Fatigue—Docetaxel—stomach cancer	0.000398	0.000521	CcSEcCtD
Goserelin—Angiopathy—Epirubicin—stomach cancer	0.000398	0.000521	CcSEcCtD
Goserelin—Urethral disorder—Doxorubicin—stomach cancer	0.000398	0.000521	CcSEcCtD
Goserelin—Nausea—Irinotecan—stomach cancer	0.000397	0.00052	CcSEcCtD
Goserelin—Immune system disorder—Epirubicin—stomach cancer	0.000396	0.000519	CcSEcCtD
Goserelin—Pain—Docetaxel—stomach cancer	0.000395	0.000517	CcSEcCtD
Goserelin—Constipation—Docetaxel—stomach cancer	0.000395	0.000517	CcSEcCtD
Goserelin—Back pain—Methotrexate—stomach cancer	0.000394	0.000517	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—PRKCB—stomach cancer	0.000394	0.00167	CbGpPWpGaD
Goserelin—Dyspepsia—Capecitabine—stomach cancer	0.000393	0.000515	CcSEcCtD
Goserelin—Chills—Epirubicin—stomach cancer	0.000393	0.000515	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ANXA1—stomach cancer	0.000393	0.00166	CbGpPWpGaD
Goserelin—Arrhythmia—Epirubicin—stomach cancer	0.000392	0.000513	CcSEcCtD
Goserelin—Decreased appetite—Capecitabine—stomach cancer	0.000389	0.000509	CcSEcCtD
Goserelin—Alopecia—Epirubicin—stomach cancer	0.000387	0.000507	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FST—stomach cancer	0.000387	0.00164	CbGpPWpGaD
Goserelin—Fatigue—Capecitabine—stomach cancer	0.000385	0.000505	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ADRB2—stomach cancer	0.000385	0.00163	CbGpPWpGaD
Goserelin—Vision blurred—Methotrexate—stomach cancer	0.000384	0.000503	CcSEcCtD
Goserelin—Mental disorder—Epirubicin—stomach cancer	0.000384	0.000503	CcSEcCtD
Goserelin—Pain—Capecitabine—stomach cancer	0.000382	0.000501	CcSEcCtD
Goserelin—Constipation—Capecitabine—stomach cancer	0.000382	0.000501	CcSEcCtD
Goserelin—Malnutrition—Epirubicin—stomach cancer	0.000382	0.0005	CcSEcCtD
Goserelin—Erythema—Epirubicin—stomach cancer	0.000382	0.0005	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADRB1—stomach cancer	0.000381	0.00161	CbGpPWpGaD
Goserelin—Feeling abnormal—Docetaxel—stomach cancer	0.00038	0.000498	CcSEcCtD
Goserelin—Nausea—Fluorouracil—stomach cancer	0.00038	0.000498	CcSEcCtD
Goserelin—Eye disorder—Doxorubicin—stomach cancer	0.000379	0.000496	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—HBEGF—stomach cancer	0.000379	0.0016	CbGpPWpGaD
Goserelin—Ill-defined disorder—Methotrexate—stomach cancer	0.000378	0.000496	CcSEcCtD
Goserelin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000377	0.000495	CcSEcCtD
Goserelin—Anaemia—Methotrexate—stomach cancer	0.000377	0.000494	CcSEcCtD
Goserelin—Cardiac disorder—Doxorubicin—stomach cancer	0.000376	0.000493	CcSEcCtD
Goserelin—Flatulence—Epirubicin—stomach cancer	0.000376	0.000493	CcSEcCtD
Goserelin—Tension—Epirubicin—stomach cancer	0.000374	0.00049	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GAST—stomach cancer	0.000373	0.00158	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RGS2—stomach cancer	0.000373	0.00158	CbGpPWpGaD
Goserelin—Nervousness—Epirubicin—stomach cancer	0.000371	0.000485	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.00037	0.00156	CbGpPWpGaD
Goserelin—Back pain—Epirubicin—stomach cancer	0.000369	0.000483	CcSEcCtD
Goserelin—Feeling abnormal—Capecitabine—stomach cancer	0.000368	0.000483	CcSEcCtD
Goserelin—Angiopathy—Doxorubicin—stomach cancer	0.000368	0.000482	CcSEcCtD
Goserelin—Malaise—Methotrexate—stomach cancer	0.000368	0.000482	CcSEcCtD
Goserelin—Muscle spasms—Epirubicin—stomach cancer	0.000367	0.000481	CcSEcCtD
Goserelin—Immune system disorder—Doxorubicin—stomach cancer	0.000366	0.00048	CcSEcCtD
Goserelin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000365	0.000479	CcSEcCtD
Goserelin—Abdominal pain—Docetaxel—stomach cancer	0.000365	0.000478	CcSEcCtD
Goserelin—Body temperature increased—Docetaxel—stomach cancer	0.000365	0.000478	CcSEcCtD
Goserelin—Leukopenia—Methotrexate—stomach cancer	0.000365	0.000478	CcSEcCtD
Goserelin—Chills—Doxorubicin—stomach cancer	0.000364	0.000477	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RPS6—stomach cancer	0.000364	0.00154	CbGpPWpGaD
Goserelin—Arrhythmia—Doxorubicin—stomach cancer	0.000362	0.000475	CcSEcCtD
Goserelin—Vision blurred—Epirubicin—stomach cancer	0.00036	0.000471	CcSEcCtD
Goserelin—Alopecia—Doxorubicin—stomach cancer	0.000358	0.000469	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PRKCB—stomach cancer	0.000358	0.00151	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6ST—stomach cancer	0.000356	0.00151	CbGpPWpGaD
Goserelin—Cough—Methotrexate—stomach cancer	0.000356	0.000466	CcSEcCtD
Goserelin—Mental disorder—Doxorubicin—stomach cancer	0.000355	0.000465	CcSEcCtD
Goserelin—Urticaria—Capecitabine—stomach cancer	0.000355	0.000465	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FGG—stomach cancer	0.000354	0.0015	CbGpPWpGaD
Goserelin—Ill-defined disorder—Epirubicin—stomach cancer	0.000354	0.000464	CcSEcCtD
Goserelin—Body temperature increased—Capecitabine—stomach cancer	0.000353	0.000463	CcSEcCtD
Goserelin—Abdominal pain—Capecitabine—stomach cancer	0.000353	0.000463	CcSEcCtD
Goserelin—Convulsion—Methotrexate—stomach cancer	0.000353	0.000463	CcSEcCtD
Goserelin—Erythema—Doxorubicin—stomach cancer	0.000353	0.000462	CcSEcCtD
Goserelin—Malnutrition—Doxorubicin—stomach cancer	0.000353	0.000462	CcSEcCtD
Goserelin—Anaemia—Epirubicin—stomach cancer	0.000353	0.000462	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRB2—stomach cancer	0.00035	0.00148	CbGpPWpGaD
Goserelin—Flatulence—Doxorubicin—stomach cancer	0.000348	0.000456	CcSEcCtD
Goserelin—Myalgia—Methotrexate—stomach cancer	0.000347	0.000455	CcSEcCtD
Goserelin—Chest pain—Methotrexate—stomach cancer	0.000347	0.000455	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—stomach cancer	0.000347	0.000455	CcSEcCtD
Goserelin—Tension—Doxorubicin—stomach cancer	0.000346	0.000454	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000345	0.000452	CcSEcCtD
Goserelin—Malaise—Epirubicin—stomach cancer	0.000344	0.000451	CcSEcCtD
Goserelin—Discomfort—Methotrexate—stomach cancer	0.000343	0.000449	CcSEcCtD
Goserelin—Nervousness—Doxorubicin—stomach cancer	0.000343	0.000449	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PPP2R1A—stomach cancer	0.000343	0.00145	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000342	0.00145	CbGpPWpGaD
Goserelin—Leukopenia—Epirubicin—stomach cancer	0.000342	0.000447	CcSEcCtD
Goserelin—Back pain—Doxorubicin—stomach cancer	0.000341	0.000447	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PRKAA1—stomach cancer	0.000341	0.00144	CbGpPWpGaD
Goserelin—Hypersensitivity—Docetaxel—stomach cancer	0.00034	0.000446	CcSEcCtD
Goserelin—Muscle spasms—Doxorubicin—stomach cancer	0.000339	0.000445	CcSEcCtD
Goserelin—Palpitations—Epirubicin—stomach cancer	0.000337	0.000442	CcSEcCtD
Goserelin—Confusional state—Methotrexate—stomach cancer	0.000335	0.00044	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HBEGF—stomach cancer	0.000334	0.00141	CbGpPWpGaD
Goserelin—Cough—Epirubicin—stomach cancer	0.000333	0.000436	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—stomach cancer	0.000333	0.000436	CcSEcCtD
Goserelin—Vision blurred—Doxorubicin—stomach cancer	0.000333	0.000436	CcSEcCtD
Goserelin—Asthenia—Docetaxel—stomach cancer	0.000331	0.000434	CcSEcCtD
Goserelin—Convulsion—Epirubicin—stomach cancer	0.000331	0.000433	CcSEcCtD
Goserelin—Infection—Methotrexate—stomach cancer	0.000331	0.000433	CcSEcCtD
Goserelin—Hypertension—Epirubicin—stomach cancer	0.000329	0.000432	CcSEcCtD
Goserelin—Hypersensitivity—Capecitabine—stomach cancer	0.000329	0.000431	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RBP4—stomach cancer	0.000329	0.00139	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—stomach cancer	0.000329	0.00139	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000328	0.00138	CbGpPWpGaD
Goserelin—Ill-defined disorder—Doxorubicin—stomach cancer	0.000328	0.000429	CcSEcCtD
Goserelin—Pruritus—Docetaxel—stomach cancer	0.000327	0.000428	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—stomach cancer	0.000326	0.000427	CcSEcCtD
Goserelin—Anaemia—Doxorubicin—stomach cancer	0.000326	0.000427	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—stomach cancer	0.000326	0.000427	CcSEcCtD
Goserelin—Arthralgia—Epirubicin—stomach cancer	0.000325	0.000426	CcSEcCtD
Goserelin—Chest pain—Epirubicin—stomach cancer	0.000325	0.000426	CcSEcCtD
Goserelin—Myalgia—Epirubicin—stomach cancer	0.000325	0.000426	CcSEcCtD
Goserelin—Anxiety—Epirubicin—stomach cancer	0.000324	0.000424	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—stomach cancer	0.000323	0.000423	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000323	0.000423	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—stomach cancer	0.000322	0.000421	CcSEcCtD
Goserelin—Discomfort—Epirubicin—stomach cancer	0.000321	0.00042	CcSEcCtD
Goserelin—Asthenia—Capecitabine—stomach cancer	0.000321	0.00042	CcSEcCtD
Goserelin—Malaise—Doxorubicin—stomach cancer	0.000318	0.000417	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL6R—stomach cancer	0.000318	0.00134	CbGpPWpGaD
Goserelin—Dry mouth—Epirubicin—stomach cancer	0.000318	0.000416	CcSEcCtD
Goserelin—Anorexia—Methotrexate—stomach cancer	0.000317	0.000415	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—RHOA—stomach cancer	0.000316	0.00134	CbGpPWpGaD
Goserelin—Pruritus—Capecitabine—stomach cancer	0.000316	0.000414	CcSEcCtD
Goserelin—Leukopenia—Doxorubicin—stomach cancer	0.000316	0.000414	CcSEcCtD
Goserelin—Diarrhoea—Docetaxel—stomach cancer	0.000316	0.000414	CcSEcCtD
Goserelin—Confusional state—Epirubicin—stomach cancer	0.000314	0.000411	CcSEcCtD
Goserelin—Palpitations—Doxorubicin—stomach cancer	0.000312	0.000409	CcSEcCtD
Goserelin—Oedema—Epirubicin—stomach cancer	0.000311	0.000408	CcSEcCtD
Goserelin—Anaphylactic shock—Epirubicin—stomach cancer	0.000311	0.000408	CcSEcCtD
Goserelin—Hypotension—Methotrexate—stomach cancer	0.000311	0.000407	CcSEcCtD
Goserelin—Infection—Epirubicin—stomach cancer	0.000309	0.000405	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADRB2—stomach cancer	0.000308	0.0013	CbGpPWpGaD
Goserelin—Cough—Doxorubicin—stomach cancer	0.000308	0.000404	CcSEcCtD
Goserelin—Shock—Epirubicin—stomach cancer	0.000306	0.000401	CcSEcCtD
Goserelin—Convulsion—Doxorubicin—stomach cancer	0.000306	0.000401	CcSEcCtD
Goserelin—Diarrhoea—Capecitabine—stomach cancer	0.000306	0.000401	CcSEcCtD
Goserelin—Nervous system disorder—Epirubicin—stomach cancer	0.000305	0.0004	CcSEcCtD
Goserelin—Dizziness—Docetaxel—stomach cancer	0.000305	0.0004	CcSEcCtD
Goserelin—Thrombocytopenia—Epirubicin—stomach cancer	0.000305	0.000399	CcSEcCtD
Goserelin—Hypertension—Doxorubicin—stomach cancer	0.000305	0.000399	CcSEcCtD
Goserelin—Tachycardia—Epirubicin—stomach cancer	0.000304	0.000398	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000303	0.000397	CcSEcCtD
Goserelin—Skin disorder—Epirubicin—stomach cancer	0.000302	0.000396	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PPP2R1A—stomach cancer	0.000302	0.00128	CbGpPWpGaD
Goserelin—Hyperhidrosis—Epirubicin—stomach cancer	0.000301	0.000394	CcSEcCtD
Goserelin—Insomnia—Methotrexate—stomach cancer	0.000301	0.000394	CcSEcCtD
Goserelin—Arthralgia—Doxorubicin—stomach cancer	0.000301	0.000394	CcSEcCtD
Goserelin—Chest pain—Doxorubicin—stomach cancer	0.000301	0.000394	CcSEcCtD
Goserelin—Myalgia—Doxorubicin—stomach cancer	0.000301	0.000394	CcSEcCtD
Goserelin—Anxiety—Doxorubicin—stomach cancer	0.0003	0.000392	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—stomach cancer	0.000299	0.000391	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000298	0.000391	CcSEcCtD
Goserelin—Discomfort—Doxorubicin—stomach cancer	0.000297	0.000389	CcSEcCtD
Goserelin—Anorexia—Epirubicin—stomach cancer	0.000297	0.000389	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—stomach cancer	0.000297	0.000389	CcSEcCtD
Goserelin—Somnolence—Methotrexate—stomach cancer	0.000296	0.000388	CcSEcCtD
Goserelin—Dizziness—Capecitabine—stomach cancer	0.000296	0.000387	CcSEcCtD
Goserelin—Dry mouth—Doxorubicin—stomach cancer	0.000294	0.000385	CcSEcCtD
Goserelin—Vomiting—Docetaxel—stomach cancer	0.000294	0.000385	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—stomach cancer	0.000293	0.000384	CcSEcCtD
Goserelin—Rash—Docetaxel—stomach cancer	0.000291	0.000381	CcSEcCtD
Goserelin—Hypotension—Epirubicin—stomach cancer	0.000291	0.000381	CcSEcCtD
Goserelin—Dermatitis—Docetaxel—stomach cancer	0.000291	0.000381	CcSEcCtD
Goserelin—Confusional state—Doxorubicin—stomach cancer	0.000291	0.000381	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—stomach cancer	0.000289	0.000379	CcSEcCtD
Goserelin—Headache—Docetaxel—stomach cancer	0.000289	0.000379	CcSEcCtD
Goserelin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000288	0.000377	CcSEcCtD
Goserelin—Oedema—Doxorubicin—stomach cancer	0.000288	0.000377	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—RHOA—stomach cancer	0.000287	0.00121	CbGpPWpGaD
Goserelin—Fatigue—Methotrexate—stomach cancer	0.000287	0.000376	CcSEcCtD
Goserelin—Infection—Doxorubicin—stomach cancer	0.000286	0.000375	CcSEcCtD
Goserelin—Pain—Methotrexate—stomach cancer	0.000285	0.000373	CcSEcCtD
Goserelin—Vomiting—Capecitabine—stomach cancer	0.000284	0.000372	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000284	0.000372	CcSEcCtD
Goserelin—Shock—Doxorubicin—stomach cancer	0.000283	0.000371	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HSPB1—stomach cancer	0.000283	0.0012	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGTR2—stomach cancer	0.000283	0.0012	CbGpPWpGaD
Goserelin—Nervous system disorder—Doxorubicin—stomach cancer	0.000283	0.00037	CcSEcCtD
Goserelin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000282	0.00037	CcSEcCtD
Goserelin—Rash—Capecitabine—stomach cancer	0.000282	0.000369	CcSEcCtD
Goserelin—Insomnia—Epirubicin—stomach cancer	0.000282	0.000369	CcSEcCtD
Goserelin—Dermatitis—Capecitabine—stomach cancer	0.000282	0.000369	CcSEcCtD
Goserelin—Tachycardia—Doxorubicin—stomach cancer	0.000281	0.000368	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SMAD4—stomach cancer	0.000281	0.00119	CbGpPWpGaD
Goserelin—Headache—Capecitabine—stomach cancer	0.00028	0.000367	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—BMP2—stomach cancer	0.00028	0.00118	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2R—stomach cancer	0.00028	0.00118	CbGpPWpGaD
Goserelin—Skin disorder—Doxorubicin—stomach cancer	0.00028	0.000367	CcSEcCtD
Goserelin—Paraesthesia—Epirubicin—stomach cancer	0.00028	0.000366	CcSEcCtD
Goserelin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000279	0.000365	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—stomach cancer	0.000278	0.00117	CbGpPWpGaD
Goserelin—Dyspnoea—Epirubicin—stomach cancer	0.000278	0.000364	CcSEcCtD
Goserelin—Somnolence—Epirubicin—stomach cancer	0.000277	0.000363	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AKR1C3—stomach cancer	0.000275	0.00116	CbGpPWpGaD
Goserelin—Anorexia—Doxorubicin—stomach cancer	0.000275	0.00036	CcSEcCtD
Goserelin—Nausea—Docetaxel—stomach cancer	0.000274	0.000359	CcSEcCtD
Goserelin—Feeling abnormal—Methotrexate—stomach cancer	0.000274	0.000359	CcSEcCtD
Goserelin—Dyspepsia—Epirubicin—stomach cancer	0.000274	0.000359	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HTR1A—stomach cancer	0.000272	0.00115	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000272	0.000356	CcSEcCtD
Goserelin—Decreased appetite—Epirubicin—stomach cancer	0.000271	0.000355	CcSEcCtD
Goserelin—Hypotension—Doxorubicin—stomach cancer	0.000269	0.000353	CcSEcCtD
Goserelin—Fatigue—Epirubicin—stomach cancer	0.000268	0.000352	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FYN—stomach cancer	0.000266	0.00113	CbGpPWpGaD
Goserelin—Pain—Epirubicin—stomach cancer	0.000266	0.000349	CcSEcCtD
Goserelin—Constipation—Epirubicin—stomach cancer	0.000266	0.000349	CcSEcCtD
Goserelin—Nausea—Capecitabine—stomach cancer	0.000265	0.000348	CcSEcCtD
Goserelin—Urticaria—Methotrexate—stomach cancer	0.000264	0.000346	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PRKCB—stomach cancer	0.000264	0.00111	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ANXA1—stomach cancer	0.000263	0.00111	CbGpPWpGaD
Goserelin—Body temperature increased—Methotrexate—stomach cancer	0.000263	0.000345	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—stomach cancer	0.000263	0.000345	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000262	0.000344	CcSEcCtD
Goserelin—Insomnia—Doxorubicin—stomach cancer	0.000261	0.000341	CcSEcCtD
Goserelin—Paraesthesia—Doxorubicin—stomach cancer	0.000259	0.000339	CcSEcCtD
Goserelin—Dyspnoea—Doxorubicin—stomach cancer	0.000257	0.000336	CcSEcCtD
Goserelin—Feeling abnormal—Epirubicin—stomach cancer	0.000257	0.000336	CcSEcCtD
Goserelin—Somnolence—Doxorubicin—stomach cancer	0.000256	0.000336	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRB1—stomach cancer	0.000255	0.00108	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000255	0.000334	CcSEcCtD
Goserelin—Dyspepsia—Doxorubicin—stomach cancer	0.000254	0.000332	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—stomach cancer	0.000252	0.00107	CbGpPWpGaD
Goserelin—Decreased appetite—Doxorubicin—stomach cancer	0.00025	0.000328	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FGFR2—stomach cancer	0.00025	0.00106	CbGpPWpGaD
Goserelin—Fatigue—Doxorubicin—stomach cancer	0.000248	0.000325	CcSEcCtD
Goserelin—Urticaria—Epirubicin—stomach cancer	0.000247	0.000324	CcSEcCtD
Goserelin—Pain—Doxorubicin—stomach cancer	0.000246	0.000323	CcSEcCtD
Goserelin—Constipation—Doxorubicin—stomach cancer	0.000246	0.000323	CcSEcCtD
Goserelin—Body temperature increased—Epirubicin—stomach cancer	0.000246	0.000322	CcSEcCtD
Goserelin—Abdominal pain—Epirubicin—stomach cancer	0.000246	0.000322	CcSEcCtD
Goserelin—Hypersensitivity—Methotrexate—stomach cancer	0.000245	0.000321	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RPS6—stomach cancer	0.000243	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCB—stomach cancer	0.00024	0.00101	CbGpPWpGaD
Goserelin—Asthenia—Methotrexate—stomach cancer	0.000239	0.000313	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL6ST—stomach cancer	0.000239	0.00101	CbGpPWpGaD
Goserelin—Feeling abnormal—Doxorubicin—stomach cancer	0.000237	0.000311	CcSEcCtD
Goserelin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000236	0.000309	CcSEcCtD
Goserelin—Pruritus—Methotrexate—stomach cancer	0.000235	0.000308	CcSEcCtD
Goserelin—Hypersensitivity—Epirubicin—stomach cancer	0.000229	0.000301	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IRS2—stomach cancer	0.000229	0.000968	CbGpPWpGaD
Goserelin—Urticaria—Doxorubicin—stomach cancer	0.000229	0.0003	CcSEcCtD
Goserelin—Body temperature increased—Doxorubicin—stomach cancer	0.000228	0.000298	CcSEcCtD
Goserelin—Abdominal pain—Doxorubicin—stomach cancer	0.000228	0.000298	CcSEcCtD
Goserelin—Diarrhoea—Methotrexate—stomach cancer	0.000228	0.000298	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HBEGF—stomach cancer	0.000224	0.000945	CbGpPWpGaD
Goserelin—Asthenia—Epirubicin—stomach cancer	0.000223	0.000293	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CAV1—stomach cancer	0.000222	0.000938	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOA1—stomach cancer	0.000222	0.000936	CbGpPWpGaD
Goserelin—Pruritus—Epirubicin—stomach cancer	0.00022	0.000289	CcSEcCtD
Goserelin—Dizziness—Methotrexate—stomach cancer	0.00022	0.000288	CcSEcCtD
Goserelin—Diarrhoea—Epirubicin—stomach cancer	0.000213	0.000279	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL6R—stomach cancer	0.000213	0.000899	CbGpPWpGaD
Goserelin—Hypersensitivity—Doxorubicin—stomach cancer	0.000212	0.000278	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—RHOA—stomach cancer	0.000212	0.000895	CbGpPWpGaD
Goserelin—Vomiting—Methotrexate—stomach cancer	0.000212	0.000277	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PRKCB—stomach cancer	0.000211	0.000893	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6ST—stomach cancer	0.000211	0.00089	CbGpPWpGaD
Goserelin—Rash—Methotrexate—stomach cancer	0.00021	0.000275	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—stomach cancer	0.00021	0.000275	CcSEcCtD
Goserelin—Headache—Methotrexate—stomach cancer	0.000208	0.000273	CcSEcCtD
Goserelin—Asthenia—Doxorubicin—stomach cancer	0.000207	0.000271	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRB2—stomach cancer	0.000206	0.000872	CbGpPWpGaD
Goserelin—Dizziness—Epirubicin—stomach cancer	0.000206	0.00027	CcSEcCtD
Goserelin—Pruritus—Doxorubicin—stomach cancer	0.000204	0.000267	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PPP2R1A—stomach cancer	0.000202	0.000855	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APC—stomach cancer	0.000202	0.000855	CbGpPWpGaD
Goserelin—Vomiting—Epirubicin—stomach cancer	0.000198	0.000259	CcSEcCtD
Goserelin—Nausea—Methotrexate—stomach cancer	0.000198	0.000259	CcSEcCtD
Goserelin—Diarrhoea—Doxorubicin—stomach cancer	0.000197	0.000258	CcSEcCtD
Goserelin—Rash—Epirubicin—stomach cancer	0.000196	0.000257	CcSEcCtD
Goserelin—Dermatitis—Epirubicin—stomach cancer	0.000196	0.000257	CcSEcCtD
Goserelin—Headache—Epirubicin—stomach cancer	0.000195	0.000256	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—MAPK3—stomach cancer	0.000194	0.000819	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RHOA—stomach cancer	0.000192	0.000812	CbGpPWpGaD
Goserelin—Dizziness—Doxorubicin—stomach cancer	0.000191	0.00025	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SMAD4—stomach cancer	0.000188	0.000794	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6R—stomach cancer	0.000188	0.000794	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—stomach cancer	0.000186	0.000785	CbGpPWpGaD
Goserelin—Nausea—Epirubicin—stomach cancer	0.000185	0.000242	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—MAPK1—stomach cancer	0.000184	0.000779	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—stomach cancer	0.000184	0.000779	CbGpPWpGaD
Goserelin—Vomiting—Doxorubicin—stomach cancer	0.000183	0.00024	CcSEcCtD
Goserelin—Rash—Doxorubicin—stomach cancer	0.000182	0.000238	CcSEcCtD
Goserelin—Dermatitis—Doxorubicin—stomach cancer	0.000181	0.000238	CcSEcCtD
Goserelin—Headache—Doxorubicin—stomach cancer	0.00018	0.000236	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FYN—stomach cancer	0.000178	0.000754	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—stomach cancer	0.000176	0.000744	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—stomach cancer	0.000176	0.000743	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KRAS—stomach cancer	0.000174	0.000736	CbGpPWpGaD
Goserelin—Nausea—Doxorubicin—stomach cancer	0.000171	0.000224	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RHOA—stomach cancer	0.00017	0.000717	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—stomach cancer	0.000169	0.000713	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—stomach cancer	0.000168	0.00071	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGFR2—stomach cancer	0.000167	0.000708	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—stomach cancer	0.00016	0.000676	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB2—stomach cancer	0.000157	0.000664	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS2—stomach cancer	0.000153	0.000648	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—stomach cancer	0.000149	0.000629	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CAV1—stomach cancer	0.000149	0.000628	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—stomach cancer	0.000148	0.000627	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HRAS—stomach cancer	0.000148	0.000625	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1B—stomach cancer	0.000145	0.000615	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—stomach cancer	0.000142	0.000599	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCB—stomach cancer	0.000142	0.000598	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6ST—stomach cancer	0.000141	0.000596	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCND1—stomach cancer	0.000139	0.000586	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JUN—stomach cancer	0.000138	0.000585	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APC—stomach cancer	0.000135	0.000572	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—stomach cancer	0.000135	0.000569	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1A—stomach cancer	0.000134	0.000567	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK8—stomach cancer	0.000131	0.000554	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK3—stomach cancer	0.00013	0.000548	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6R—stomach cancer	0.000126	0.000531	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK1—stomach cancer	0.000123	0.000521	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—stomach cancer	0.000123	0.000521	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—stomach cancer	0.000121	0.000511	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—stomach cancer	0.00012	0.000506	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—stomach cancer	0.000118	0.000498	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—stomach cancer	0.000118	0.000498	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—stomach cancer	0.000117	0.000492	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK3—stomach cancer	0.000114	0.000484	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RHOA—stomach cancer	0.000114	0.00048	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—stomach cancer	0.000112	0.000475	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—stomach cancer	0.000111	0.00047	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK1—stomach cancer	0.000109	0.00046	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—stomach cancer	0.000109	0.00046	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—stomach cancer	0.000107	0.000452	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB2—stomach cancer	0.000105	0.000444	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—stomach cancer	0.000103	0.000435	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—stomach cancer	9.97e-05	0.000421	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRAS—stomach cancer	9.91e-05	0.000419	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1B—stomach cancer	9.74e-05	0.000411	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—stomach cancer	9.48e-05	0.000401	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—stomach cancer	9.45e-05	0.000399	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—stomach cancer	9.29e-05	0.000393	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JUN—stomach cancer	9.27e-05	0.000392	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—stomach cancer	9.14e-05	0.000386	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—stomach cancer	9.02e-05	0.000381	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1A—stomach cancer	8.99e-05	0.00038	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK8—stomach cancer	8.77e-05	0.000371	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRAS—stomach cancer	8.74e-05	0.000369	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—stomach cancer	8.37e-05	0.000354	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—stomach cancer	8.1e-05	0.000342	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—stomach cancer	8.02e-05	0.000339	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK3—stomach cancer	7.66e-05	0.000324	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—stomach cancer	7.45e-05	0.000315	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK1—stomach cancer	7.29e-05	0.000308	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—stomach cancer	7.29e-05	0.000308	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—stomach cancer	6.89e-05	0.000291	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—stomach cancer	6.33e-05	0.000267	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—stomach cancer	6.12e-05	0.000259	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRAS—stomach cancer	5.85e-05	0.000247	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—stomach cancer	5.6e-05	0.000237	CbGpPWpGaD
